View 
FILTERS (0)
* Not connected to ResearchPool

MORE FILTERS

  
reports
Oliver Metzger
  • Oliver Metzger

Merck KGaA : Kai’s homework

Strategic decisions will come into the focus of Kai Beckmann after he takes over the CEO role, in our view. We identify the Healthcare segment as being in the focus on improving its growth profile through divestments and acquisitions. Divesting the MS business would boost the segmental sales CAGR to 3.1% from 1.0%. We see more opportunity on the upside and reiterate our Outperform rating with a new target price of € 151.

Arancha Pineiro
  • Arancha Pineiro

ADIDAS AG: RDOS. PRELIMINARES 4T’25 (ANÁLISIS BANCO SABADELL)

Rdos. 4T'25 vs 4T'24: Ventas: 6.076 M euros (+1,9% vs +5,1% BS(e) y +3,8% consenso); EBIT: 164,0 M euros (+187,7% vs +171,9% BS(e) y +179,6% consenso); Rdos. 2025 vs 2024: Ventas: 24.811 M euros (+4,8% vs +5,6% BS(e) y +5,2% consenso); EBIT: 2.056 M euros (+53,8% vs +46,8% BS(e) y +50,3% consenso).

Loading...
New interest

Save your current filters as a new Interest

Please enter a name for this interest

Email alerts

Would you like to receive real-time email alerts when a new report is published under this interest?

Save This Search

These search results will show up under 'Saved searches' in the left panel

Please enter a name for this saved search

ResearchPool Subscriptions

Get the most out of your insights

Get in touch